3654 results for «209»

Filter By

3654 results

Learn the procedure technique - Lifetime management of aortic stenosis therapy with self-expandable valve

18 Feb 2024 – From PCR Tokyo Valves 2024

In this session, learn all about the excellent characteristics of the latest self-expandable valve system and its use during the lifetime management of aortic stenosis therapy. Find out more about how we can effectively and safely perform procedures for various cases with the latest self-expandable valve,...

TAVI in bicuspid anatomy

18 Feb 2024 – From PCR Tokyo Valves 2024

Delve into the complexities of TAVI within bicuspid anatomy through this selection of cases: learn about the challenges and techniques involved in overcoming the horizontal aorta, explore how to size  the transcatheter aortic valve in severely calcified bicuspid anatomy, and more!

Tricuspid and other structural interventions

18 Feb 2024 – From PCR Tokyo Valves 2024

In this series of submitted cases, explore challenges and bailouts around tricuspid valve intervention and other forms of structural interventions. Learn about a percutaneous solution to acute traumatic pulmonary regurgitation, a rare complication of inadequate sealing caused by anchor slip through the fabric part in a...

Rapid-fire - Complex procedure in TAVI - Part 2

18 Feb 2024 – From PCR Tokyo Valves 2024

In the second part of this rapid-fire session, we continue to focus on complex cases that might arise during TAVI, such as a case of prosthetic aortic valve endocarditis resulting in cardiogenic shock,  treatment of severe AR after infective endocarditis, and more!

Rapid-fire - Complications of Mitral TEER - Part 2

18 Feb 2024 – From PCR Tokyo Valves 2024

Gain valuable insights into the possible complications of Mitral Transcatheter Edge-to-Edge Repair (TEER) in the second part of this session rapid-fire submission cases [in Japanese].

Nightmares in TAVI: sharing solutions together

18 Feb 2024 – From PCR Tokyo Valves 2024

Consult this session to learn more about bailout techniques for TAVI during uncommon complications, such as late coronary obstruction post-TAVI, a migrated self-expandable valve, or a C-tab induced iatrogenic thoracic aortic dissection after Evolut FX implantation.

Imaging for aortic valve disease

18 Feb 2024 – From PCR Tokyo Valves 2024

Learn about imaging of the aortic valve system in order to better deal with aortic valve disease. Through this series of cases, explore topics such as the impact of implantation depth relative to membranous septum on TAVI outcomes, delve into a meta-analysis exploring the outcomes of...

Rapid-fire - Pulmonary and tricuspid valve implantation

18 Feb 2024 – From PCR Tokyo Valves 2024

In this series of rapid-fire case submissions, gain insight into pulmonary and tricuspid valve implantation. This session explores cases such as a pulmonary valve-in-valve procedure, dealing with tissue valve degeneration, and valve implantation in a calcified RV-PA conduit.

Rapid-fire - Pulmonary and tricuspid valve implantation

SMT’s Hydra TAVR Valve demonstrates sustained safety, durability, and hemodynamic performance at 5 Years

19 Nov 2025

MASTER-DAPT: “the MASTER of high-bleeding risk trials”

28 Aug 2021

Marco Valgimigli (Lugano, Switzerland) presented the results of the MASTER DAPT trial on Saturday, August 28, in a Hot Line session of the ESC Congress 2021. Luis G. Ortega-Paz provides his PICOT & SWOT analysis of this study.

Luis Ortega-Paz

Author

Luis Ortega-Paz
ESC Congress 2021 - MASTER-DAPT : “the MASTER of high-bleeding risk trials”

On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

05 Mar 2023

Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

04 Nov 2024

Alex Sticchi provides his take on the results of the TRISCEND II trial presented by Susheel K. Kodali and Suzanne V. Arnold at TCT 2024 in Washington.

Also watch the interview with Susheel K. Kodali

Alessandro Sticchi

Author

Alessandro Sticchi
TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR

29 Mar 2025

Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.

Nicola Ammirabile

Author

Nicola Ammirabile
Daniele Giacoppo

Author

Daniele Giacoppo
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR

HOST-EXAM:10-year follow-up of clopidogrel vs aspirin monotherapy in stable CAD after PCI with drug-eluting stent

30 Mar 2026

Nicola Ryan provides her take on the 10-year follow-up of the HOST-EXAM, which was presented by Hyo-Soo Kim at ACC.26 in New Orleans.

Nicola Ryan

Author

Nicola Ryan
10-year follow-up of clopidogrel vs aspirin monotherapy in stable coronary artery disease after percutaneous coronary intervention with drug-eluting stent
Didn’t find what you were looking for?